Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma—Data From the Multinational LITCHI Registry
Ulrike Bauer, Maria R. Troppmair, Najib Ben Khaled, Julia M. Grottenthaler et autres
Evidence supporting the safety and efficacy of immune checkpoint inhibitors (ICI) before liver transplantation (LTx) in hepatocellular carcinoma (HCC) is increasing, but risks of graft rejection and tumour recurrence remain major concerns. We evaluated post-transplant outcomes across 10 European centres using data …
in, at, de, ch (code pays fourni par la source)
0 citations
Liver International